
Prostate Cancer Drug Therapy: What Have Clinicians Missed During the COVID-19 Pandemic
Author(s) -
Mohammad Sajjad Rahnama’i
Publication year - 2022
Publication title -
american journal of men's health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.881
H-Index - 34
eISSN - 1557-9891
pISSN - 1557-9883
DOI - 10.1177/15579883221115593
Subject(s) - enzalutamide , cabazitaxel , docetaxel , prostate cancer , medicine , oncology , androgen deprivation therapy , clinical trial , cancer , androgen receptor